#1 Clinical Trials Search in Europe

Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

↓

Matched clinical trials

  • Study of Pembrolizumab with Chemotherapy for Children and Young Adults with Classical Hodgkin Lymphoma Not Responding Well to Initial Treatment

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Czechia France Germany Greece Italy The Netherlands +2

  • Study on Galcanezumab for Preventing Episodic Migraine in Children and Teens Aged 6 to 17

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Denmark Italy The Netherlands Spain

  • Study on Galcanezumab for Preventing Chronic Migraine in Adolescents Aged 12 to 17

    Not recruiting

    3 1
    Investigated drugs:
    Denmark France Italy The Netherlands Spain

  • Study on the Effectiveness and Safety of JNJ-77242113 for Treating Plaque Psoriasis in Special Areas for Patients with Moderate to Severe Symptoms

    Not recruiting

    3 1
    Investigated drugs:
    Germany Hungary Poland Spain

  • Study on Cannabidiol Oral Solution for Infants with Tuberous Sclerosis, Dravet Syndrome, or Lennox-Gastaut Syndrome Experiencing Uncontrolled Seizures

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy Spain

  • Study on Larotrectinib for Treating Children with Advanced Solid Tumors with NTRK Fusion

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Denmark France Germany Ireland Italy +3

  • Study on the Effects and Safety of Dupilumab for Children Aged 2 to Under 6 with Uncontrolled Asthma or Severe Asthmatic Wheeze

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia France Germany Greece Hungary Italy +3

  • Study on the Safety and Effects of Risdiplam for Adults and Children with Spinal Muscular Atrophy

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Italy The Netherlands Poland

  • Study on the Safety and Effectiveness of Mirabegron for Children Aged 6 Months to Under 3 Years with Neurogenic Detrusor Overactivity

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Denmark Germany Poland

  • Study on the Safety and Effects of Ocrelizumab for Children and Adolescents with Relapsing-Remitting Multiple Sclerosis

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy Poland